GlassScriptPhysician profile
Charles Yoon Kim
NPI 1528234804
$50,127.09
in general payments reported to CMS, 2019-2025
22 companies · $9,202 in 2025
The $9,202 reported for 2025 was more than what 89% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $5,000 · 2021: $16K · 2022: $3,159 · 2023: $4,131 · 2024: $1,116 · 2025: $9,202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,300 · Food and Beverage: $4,958 · Travel and Lodging: $1,731 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,300.00 |
| Food and Beverage | $4,957.96 |
| Travel and Lodging | $1,730.97 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,460.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $16,635.39 | 2021-2023 | Venovo, Fluency Endovascular Stent Graft |
| Boston Scientific Corporation | $7,301.95 | 2019-2025 | Embold Fibered, Obsidio |
| Genentech, INC. | $7,252.47 | 2019 | |
| Baylis Medical Technologies INC. | $6,300.00 | 2023-2025 | |
| Siemens Medical Solutions USA, INC. | $2,264.50 | 2024-2025 | Artis Icono Floor, Naeotom Alpha |
| Biocompatibles Uk LTD | $1,875.00 | 2019 | |
| Becton, Dickinson and Company | $1,460.00 | 2025 | |
| Philips North America LLC | $1,273.83 | 2019-2020 | |
| Sirtex Medical INC | $1,154.08 | 2019-2025 | Lava Les (Liquid Embolic System) |
| Medtronic, INC. | $814.85 | 2022-2025 | Emprint, Concertotm, Abre |
| Inari Medical, INC. | $790.80 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Penumbra, INC. | $565.59 | 2019-2025 | Indigo System |
| W. L. Gore & Associates, INC. | $550.25 | 2019-2025 | Viatorr Endoprosthesis |
| Angiodynamics, INC. | $505.99 | 2019-2025 | Alphavac |
| Terumo Medical Corporation | $275.99 | 2019-2025 | Azur Cx Detachable |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $245.05 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $176.12 | 2019-2024 | Perclose Prostyle |
| Ge Healthcare | $166.53 | 2019 | |
| Cook Medical LLC | $146.52 | 2019-2023 | Cook |
| Ethicon US, LLC | $140.00 | 2024 | Certus 140 |
| Medtronic Vascular, INC. | $135.46 | 2019-2020 | |
| Trisalus Life Sciences, INC. | $96.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.